CoChat

Assessment in Work Productivity and the Relationship with Cognitive Symptoms (AtWoRC): primary analysis from a Canadian open-label study of vortioxetine in patients with major depressive disorder (MDD)

Open access
Chokka, Pratap, Bougie, Joanna, Rampakakis, Emmanouil, Proulx, Jean · 2019 · CNS Spectrums

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

Abstract

Objective: The Assessment in Work Productivity and the Relationship with Cognitive Symptoms (AtWoRC) study aimed to assess the association between cognitive symptoms and work productivity in gainfully employed patients receiving vortioxetine for a major depressive episode (MDE). Methods: Patients diagnosed with major depressive disorder (MDD) and treated with vortioxetine independently of study enrollment were assessed over 52 weeks at visits that emulated a real-life setting. Patients were classified as those receiving vortioxetine as the first treatment for their current MDE (first treatment) or having shown inadequate response to a previous antidepressant (switch). The primary endpoint was the correlation between changes in patient-reported cognitive symptoms (20-item Perceived Deficits Questionnaire [PDQ-D-20]) and changes in work productivity loss (Work Limitations Questionnaire [WLQ]) at week 12. Additional assessments included changes in symptom and disease severity, cognitive performance, functioning, work loss, and safety. Results: In the week 12 primary analysis, 196 eligible patients at 26 Canadian sites were enrolled, received at least one treatment dose, and attended at least one postbaseline study visit. This analysis demonstrated a significant, strong correlation between PDQ-D-20 and WLQ productivity loss scores (r=0.634; p<0.001), and this correlation was significant in both first treatment and switch patients (p<0.001). A weaker correlation between Digit Symbol Substitution Test and WLQ scores was found (r=−0.244; p=0.003). Conclusion: At 12 weeks, improvements in cognitive dysfunction were significantly associated with improvements in workplace productivity in patients with MDD, suggesting a role for vortioxetine in functional recovery in MDD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s1092852918000913

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Study design of the AtWoRC study. MDE=major depression episode
Figure 1 Study design of the AtWoRC study. MDE=major depression episodeCC BY · PubMed Central
Figure 2 Patient disposition. *“Completed” refers to those who attended the Week 12 visit. “Discontinued” refers to treatment discontinuation before Week 12. †Ongoing analysis. APTS=all patients treated set; FAS=full analysis set
Figure 2 Patient disposition. *“Completed” refers to those who attended the Week 12 visit. “Discontinued” refers to treatment discontinuation before Week 12. †Ongoing analysis. APTS=all patients treated set; FAS=full analysis setCC BY · PubMed Central
Figure 3 Response and remission rates at Week 12 (OC). FAS=Full Analysis Set; OC=observed cases
Figure 3 Response and remission rates at Week 12 (OC). FAS=Full Analysis Set; OC=observed casesCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 59 references

Research works printed but not linked: 1

  1. Southerland, 2016, Healthy Brains at Work: Estimating the Impact of Workplace Mental Health Benefits and Programs

Cited by

See all 49

Metadata

Authors
Chokka, P., Bougie, J., Rampakakis, E., & Proulx, J.
Affiliations
  • Grey Nuns Community Hospital (CA)
  • Lundbeck Canada (Canada) (CA)
Corresponding author
Chokka, Pratap
Venue
CNS Spectrums
Published
2018-05-24
Volume
24
Issue
3
Pages
338-347
ISSN
  • 1092-8529 (ISSN-L)
  • 2165-6509
OpenAlex
W2803911854
Cited by
48
References
59
Citations by year
2026: 3 · 2025: 4 · 2024: 4 · 2023: 4 · 2022: 9 · 2021: 4 · 2020: 5 · 2019: 14 · 2018: 1
FWCI
3.87
Type
journal article
Language
en
Open access
Locations
  • CNS Spectrums (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • H. Lundbeck A/S
  • Lundbeck Canada
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Workplace Health and Well-being
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Keywords
vortioxetine, major depressive disorder, labor productivity, cognitive symptoms, cognitive impairment, work limitations, Work Limitations Questionnaire, Digit Symbol Substitution Test, antidepressant treatment, functional recovery, employed patients
MeSH terms
Work Performance, Vortioxetine, Adult, Antidepressive Agents, Cognition, Major Depressive Disorder, Female, Humans, Male, Middle Aged

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Assessment in Work Productivity and the Relationship with Cognitive Symptoms (AtWoRC): primary analysis from a Canadian open-label study of vortioxetine in patients with major depressive disorder (MDD). https://app.cochat.ai/papers/10.1017/s1092852918000913
The paper
Chokka, P., Bougie, J., Rampakakis, E., & Proulx, J. (2019). Assessment in Work Productivity and the Relationship with Cognitive Symptoms (AtWoRC): primary analysis from a Canadian open-label study of vortioxetine in patients with major depressive disorder (MDD). CNS Spectrums. https://doi.org/10.1017/s1092852918000913

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.